AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CHLORAMPHENICOL SODIUM SUCCINATE
17 registrations across 4 African markets— 8 active
Markets with CHLORAMPHENICOL SODIUM SUCCINATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CHLORAMPHENICOL SODIUM SUCCINATE POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | MACLEODS PHARMACEUTICALS LTD | active | Nov 2028 |
| CHLORAMPHENICOL SODIUM SUCCINATE POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | CAPS PVT LTD | active | Dec 2027 |
| EUCHLOR-1000 1000MG INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2023 |
| CHLORAMPHENICOL 1GM INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2019 |
| CHLORAMPHENICOL_SODIUM 1G/VIAL INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2017 |
| CHLORAMPHENICOL_SODIUM_SUCCINATE 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2016 |
| CHLORAMPHENICOL 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2008 |
| CHLORAMPHENICOL 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Nov 2005 |
| BRAVOCAF 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Apr 2005 |
| SENTALLORIN 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Apr 2001 |
| SENTAKLORIN 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Apr 2001 |
| CHLORAMPHENICOL
SODIUM SUCCINATE PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | NEON LABARATORIES LTD. | active | — |
| CHLORAMPHENICOL
SODIUM SUCCINATE PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | ROYAL PHARMA 2011 LIMITED | active | — |
| Chloramphenicol Powder for solution for injection | 🇹🇿Tanzania | Macleods Pharmaceuticals Limited | active | — |
| EUCHLOR-1000 Powder for solution for injection | 🇹🇿Tanzania | Umedica Laboratories Private Limited | active | — |
| CHLORAMPHENICOL
SODIUM SUCCINATE PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | NEON LABARATORIES LTD. | active | — |
| CHLORAMPHENICOL
SODIUM SUCCINATE PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | ROYAL PHARMA 2011 LIMITED | active | — |
CHLORAMPHENICOL SODIUM SUCCINATE in Africa — Regulatory Overview
CHLORAMPHENICOL SODIUM SUCCINATE is registered across 4 African markets with 17 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Uganda, Tanzania, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 17 registrations, 8 (47%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.